COMMUNIQUÉS West-GlobeNewswire

-
Counslr Partners with Hacking HR to Provide 24/7 Mental Health Support for Members
17/06/2025 -
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
17/06/2025 -
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
17/06/2025 -
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
17/06/2025 -
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
17/06/2025 -
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
17/06/2025 -
Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples
17/06/2025 -
Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections
17/06/2025 -
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
17/06/2025 -
Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress
17/06/2025 -
Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk
17/06/2025 -
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
17/06/2025 -
TLI Executive Director Featured in Medical Economics: New Article Highlights Innovations In Autism Care Models
16/06/2025 -
Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
16/06/2025 -
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
16/06/2025 -
Streamline Health® Reports Fiscal First Quarter 2025 Financial Results
16/06/2025 -
Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
16/06/2025 -
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing
16/06/2025 -
Elizabeth Holmes Is in Prison But 'Theranos 2.0' Just Hit the Market
16/06/2025
Pages